However, neither ERG nor AR possess clustered promoter binding sites in the promoter of the MCOLN2 gene and, therefore, MCOLN2 up-regulation in prostate cancers with ERG over-expression is not directly performed by these transcription factors. This evidence concerns the gene AR and prostate carcinoma.